
Exagen XGN
$ 6.05
-1.39%
Quarterly report 2025-Q3
added 11-04-2025
Exagen P/E Ratio 2011-2025 | XGN
Annual P/E Ratio Exagen
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -1.32 | -0.851 | -4.52 | -11.9 | -6.69 | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -0.851 | -11.9 | -5.06 |
P/E Ratio of other stocks in the Diagnostics research industry
| Issuer | P/E Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
-10.3 | - | -6.23 % | $ 30.6 M | ||
|
Akumin
AKU
|
-0.479 | - | -17.87 % | $ 25.9 M | ||
|
Accelerate Diagnostics
AXDX
|
-2.76 | - | -61.36 % | $ 2.46 M | ||
|
Brainsway Ltd.
BWAY
|
-37.1 | $ 18.71 | -3.41 % | $ 99.4 M | ||
|
Burning Rock Biotech Limited
BNR
|
-7.25 | $ 20.72 | -2.15 % | $ 223 M | ||
|
Co-Diagnostics
CODX
|
-0.988 | $ 0.23 | -1.28 % | $ 6.75 M | ||
|
Biocept
BIOC
|
-0.185 | - | -13.05 % | $ 7.29 M | ||
|
Chembio Diagnostics
CEMI
|
-0.54 | - | 0.22 % | $ 16.8 M | ||
|
Castle Biosciences
CSTL
|
38.9 | $ 39.08 | -0.8 % | $ 1.09 B | ||
|
Danaher Corporation
DHR
|
39 | $ 230.45 | 0.06 % | $ 168 B | ||
|
BioNano Genomics
BNGO
|
-0.0317 | $ 1.5 | -1.28 % | $ 1.91 M | ||
|
DarioHealth Corp.
DRIO
|
-0.73 | $ 10.65 | 6.03 % | $ 302 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
-233 | - | - | $ 562 M | ||
|
Exact Sciences Corporation
EXAS
|
-10.8 | $ 101.57 | - | $ 18.8 B | ||
|
DexCom
DXCM
|
90.1 | $ 67.66 | 0.13 % | $ 26.1 B | ||
|
Enzo Biochem
ENZ
|
-0.00221 | - | -8.98 % | $ 14.8 K | ||
|
Fulgent Genetics
FLGT
|
-10.9 | $ 26.45 | -1.01 % | $ 800 M | ||
|
Global Cord Blood Corporation
CO
|
0.485 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
-9.08 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
-1.29 K | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-3.07 | - | 0.12 % | $ 80.1 M | ||
|
DermTech
DMTK
|
-0.421 | - | -11.32 % | $ 2.94 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
39.9 | - | - | $ 10.7 B | ||
|
CareDx, Inc
CDNA
|
-2.74 | $ 19.01 | -2.41 % | $ 1.02 B | ||
|
Celcuity
CELC
|
-3.57 | $ 101.35 | -0.88 % | $ 4 B | ||
|
Heska Corporation
HSKA
|
-42.4 | - | - | $ 1.31 B | ||
|
Anixa Biosciences
ANIX
|
-0.00564 | $ 3.17 | -0.83 % | $ 101 K | ||
|
HTG Molecular Diagnostics
HTGM
|
-0.138 | - | -20.0 % | $ 1.06 M | ||
|
IQVIA Holdings
IQV
|
26 | $ 226.47 | -0.2 % | $ 41.1 B | ||
|
Guardant Health
GH
|
-13.4 | $ 101.35 | -1.59 % | $ 12.4 B | ||
|
Myriad Genetics
MYGN
|
-7.64 | $ 6.32 | -2.41 % | $ 573 M | ||
|
Aspira Women's Health
AWH
|
-1.67 | - | -6.19 % | $ 10.5 M | ||
|
ENDRA Life Sciences
NDRA
|
-0.191 | $ 4.95 | -2.6 % | $ 2.66 M | ||
|
Neogen Corporation
NEOG
|
-0.933 | $ 7.17 | 0.56 % | $ 1.56 B | ||
|
National Research Corporation
NRC
|
32.6 | $ 18.83 | 0.88 % | $ 462 M | ||
|
Koninklijke Philips N.V.
PHG
|
9.27 | $ 27.21 | 0.37 % | $ 20 B | ||
|
Illumina
ILMN
|
-13.4 | $ 133.18 | -1.32 % | $ 21.2 B | ||
|
Charles River Laboratories International
CRL
|
385 | $ 202.55 | -0.55 % | $ 10.4 B | ||
|
Personalis
PSNL
|
-3.12 | $ 8.01 | -1.6 % | $ 475 M | ||
|
Quidel Corporation
QDEL
|
13 | $ 29.09 | -0.72 % | $ 1.23 B | ||
|
RadNet
RDNT
|
1.32 K | $ 73.13 | -0.03 % | $ 5.34 B | ||
|
Soleno Therapeutics
SLNO
|
-11.1 | $ 47.69 | 0.08 % | $ 1.92 B | ||
|
Quest Diagnostics Incorporated
DGX
|
21.9 | $ 174.88 | -0.6 % | $ 19.4 B | ||
|
Biodesix
BDSX
|
-2.14 | $ 6.65 | -2.57 % | $ 862 M | ||
|
Motus GI Holdings
MOTS
|
-0.0769 | - | -34.28 % | $ 263 K | ||
|
Laboratory Corporation of America Holdings
LH
|
28.3 | $ 252.38 | -0.59 % | $ 21.2 B | ||
|
ICON Public Limited Company
ICLR
|
21 | $ 182.35 | -0.27 % | $ 15 B | ||
|
IDEXX Laboratories
IDXX
|
42.4 | $ 682.6 | -0.85 % | $ 56.3 B | ||
|
Lantheus Holdings
LNTH
|
20.7 | $ 66.84 | 0.19 % | $ 4.63 B | ||
|
Mettler-Toledo International
MTD
|
34.6 | $ 1 407.81 | -0.87 % | $ 29.9 B |